Microaxial Flow Pump Fails to Improve Outcomes in High-Risk PCI

Managing patients with multivessel coronary artery disease and severely reduced ejection fraction remains a significant challenge for the heart team, as these individuals face high rates of periprocedural complications and long-term mortality [1, 2]. While coronary artery bypass grafting has historically been the preferred strategy for complex anatomy, percutaneous coronary intervention is increasingly utilized in patients deemed high-risk for surgery [2]. To mitigate the hemodynamic instability associated with complex stenting, clinicians often employ mechanical circulatory support to provide left ventricular unloading (a technique intended to maintain end-organ perfusion and reduce myocardial work during prolonged balloon inflations). However, the evidence supporting routine mechanical assistance in stable but high-risk settings has been less robust than the data guiding antiplatelet therapy or lipid management [3, 4]. Given the risks of vascular injury and bleeding associated with large-bore access, the necessity of prophylactic support remains a subject of intense clinical debate [5]. A new randomized controlled trial now provides definitive data on whether elective microaxial flow pump support improves long-term outcomes in this high-stakes population, offering critical guidance for interventional cardiologists weighing the risks and benefits of prophylactic mechanical assistance.